Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Final Progress Reports: University of Arizona: Role of NRF2 in the Pulmonary Response to Inhaled Mine Tailing Dust

Superfund Research Program

Role of NRF2 in the Pulmonary Response to Inhaled Mine Tailing Dust

Project Leader: Donna D. Zhang
Co-Investigators: Scott Boitano, Robert Clark Lantz
Grant Number: P42ES004940
Funding Period: 2017-2020
View this project in the NIH Research Portfolio Online Reporting Tools (RePORT)

Project-Specific Links

Connect with the Grant Recipients

Visit the grantee's eNewsletter page Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Instagram page Visit the grantee's Video page

Final Progress Reports

Year:   2019 

An increasing body of literature indicates that chronic exposure to arsenic is linked to increased risk of developing certain diseases, including lung cancer. Even though the adverse health effects associated with arsenic exposure are known, the mechanisms underlying prolonged exposure to arsenic that drive lung cancer initiation and progression have not been fully elucidated. The research team’s studies were among the first to identify that exposure to arsenic activates the Nrf2 pathway. One interesting finding from this work is that short-term activation of Nrf2 is generally protective, whereas chronic activation can lead to numerous deleterious effects, including protecting cancer cells from establish cancer treatments. As such, this project aims to determine how chronic activation of Nrf2, via repeated exposure to arsenic-containing dust particles, enhances lung tumor formation and progression, including whether or not activation of this pathway prior to exposure can lessen or prevent tumor formation. Over the past year, the research team: (1) has identified a number of biomarkers associated with chronic arsenic exposure; (2) is in the process of finalizing and analyzing tissue samples from mice exposed to arsenic-containing dust to determine what pathways downstream of Nrf2 are activated during exposure, as well as if pretreatment with an Nrf2 inducer ameliorates the pro-tumorigenic changes caused by arsenic; and (3) is building the foundation for the research team’s new projects investigating arsenic promotion of type II diabetes. The past year has increased the research team’s understanding of how arsenic-induced activation of Nrf2 promotes lung cancer, and whether therapeutic activation of Nrf2 prior to exposure can benefit exposed populations.

to Top